The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)942.00
  • Today's Change0.00 / 0.00%
  • Shares traded93.86k
  • 1 Year change+18.49%
  • Beta0.6437
Data delayed at least 20 minutes, as of Apr 18 2024 17:55 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Mar 31 2023202320222021
ASSETS
Cash And Short Term Investments2.7701.50
Total Receivables, Net------
Total Inventory------
Prepaid expenses0.020.050.04
Other current assets, total0.4904.73
Total current assets3.280.056.26
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments357427643
Note receivable - long term------
Other long term assets------
Total assets361427650
LIABILITIES
Accounts payable------
Accrued expenses--018
Notes payable/short-term debt203227
Current portion long-term debt/capital leases------
Other current liabilities, total9.100.451.98
Total current liabilities303348
Total long term debt000
Total debt203227
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities303348
SHAREHOLDERS EQUITY
Common stock9.681010
Additional paid-in capital808078
Retained earnings (accumulated deficit)241304513
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity330394601
Total liabilities & shareholders' equity361427650
Total common shares outstanding394142
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.